Transcriptional regulation of YWHAZ, the gene encoding 14-3-3ζ

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Kasinski, Andrea ^a,b,c   Dong, Xueyuan ^b   Khuri, Fadlo R ^b   Boss, Jeremy ^b   Fu, Haian ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN 14 3 3; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA; 5' UNTRANSLATED REGION; MESSENGER RNA; PROTEIN BINDING; RNA ISOFORM;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; EXPRESSED SEQUENCE TAG; FRACTIONATION; GEL MOBILITY SHIFT ASSAY; GENE; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC ORGANIZATION; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT; TRANSCRIPTION REGULATION; WESTERN BLOTTING; YWHAZ GENE; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; CELL LINE; CHEMISTRY; DRUG EFFECTS; EXON; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN SYNTHESIS; REGULATORY SEQUENCE; TRANSCRIPTION INITIATION;

14-3-3 PROTEINS; 5' UNTRANSLATED REGIONS; ACTIVATING TRANSCRIPTION FACTOR 1; ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXONS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA ISOFORMS; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898640454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093480     Document Type: Article

References (44)

1. Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and (Pubitemid 30340695)
2. Kasinski A, Fu H (2011) 14-3-3 zeta. AfCS-Nature Molecule Pages. 3. Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84: 889-897.
3. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, et al. (1997) The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91: 961-971. (Pubitemid 28027829)
4. Ganguly S, Weller JL, Ho A, Chemineau P, Malpaux B, et al. (2005) Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine Nacetyltransferase mediated by phosphoserine-205. Proc Natl Acad Sci U S A 102: 1222-1227. (Pubitemid 40170753)
5. Coblitz B, Wu M, Shikano S, Li M (2006) C-terminal binding: an expanded repertoire and function of 14-3-3 proteins. FEBS Lett 580: 1531-1535. (Pubitemid 43290346)
6. Lopez-Girona A, Furnari B, Mondesert O, Russell P (1999) Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397: 172-175.
7. Lee J, Kumagai A, Dunphy WG (2001) Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 12: 551-563. (Pubitemid 33052011)
8. Obsil T, Ghirlando R, Klein DC, Ganguly S, Dyda F (2001) Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase complex. a role for scaffolding in enzyme regulation. Cell 105: 257-267. (Pubitemid 32429515)
9. Morrison DK, Heidecker G, Rapp UR, Copeland TD (1993) Identification of the major phosphorylation sites of the Raf-1 kinase. J Biol Chem 268: 17309-17316. (Pubitemid 23236968)
10. Thorson JA, Yu LW, Hsu AL, Shih NY, Graves PR, et al. (1998) 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol 18: 5229-5238. (Pubitemid 28388106)
11. Tzivion G, Luo Z, Avruch J (1998) A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394: 88-92. (Pubitemid 28321808)
12. Braselmann S, McCormick F (1995) Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 14: 4839-4848.
13. Vincenz C, Dixit VM (1996) 14-3-3 proteins associate with A20 in an isoformspecific manner and function both as chaperone and adapter molecules. J Biol Chem 271: 20029-20034. (Pubitemid 26281752)
14. Woodcock JM, Murphy J, Stomski FC, Berndt MC, Lopez AF (2003) The dimeric versus monomeric status of 14-3-3zeta is controlled by phosphorylation of Ser58 at the dimer interface. J Biol Chem 278: 36323-36327. (Pubitemid 37139958)
15. Powell DW, Rane MJ, Joughin BA, Kalmukova R, Hong JH, et al. (2003) Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinaseactivated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol Cell Biol 23: 5376-5387. (Pubitemid 36950892)
16. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, et al. (2000) High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A 97: 6049-6054. (Pubitemid 30367521)
17. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, et al. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11. (Pubitemid 127376388)
18. Qi W, Liu X, Qiao D, Martinez JD (2005) Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113: 359-363. (Pubitemid 40038701)
19. Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, et al. (2009) 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res 69: 3425-3432.
20. Murata T, Takayama K, Urano T, Fujimura T, Ashikari D, et al. (2012) 14-3-3zeta, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival. Clin Cancer Res 18: 5617-5627.
21. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Research 12: 996-1006. (Pubitemid 34662293)
22. Pruitt KD, Tatusova T, Brown GR, Maglott DR (2012) NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res 40: D130-135.
23. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 102: 4459-4464. (Pubitemid 40397134)
24. Yamamoto KK, Gonzalez GA, Biggs WH, 3rd, Montminy MR (1988) Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334: 494-498.
25. Iguchi-Ariga SM, Schaffner W (1989) CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 3: 612-619.
26. Jornot L, Petersen H, Junod AF (1997) Modulation of the DNA binding activity of transcription factors CREP, NFkappaB and HSF by H2O2 and TNF alpha. Differences between in vivo and in vitro effects. FEBS Lett 416: 381-386. (Pubitemid 27475402)
27. Pomerantz JL, Baltimore D (2002) Two pathways to NF-kappaB. Mol Cell 10: 693-695.
28. Cao L, Cao W, Zhang W, Lin H, Yang X, et al. (2008) Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry. Neurosci Lett 432: 94-99.
29. Matta A, Bahadur S, Duggal R, Gupta SD, Ralhan R (2007) Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer 7: 169.
30. Fan T, Li R, Todd NW, Qiu Q, Fang HB, et al. (2007) Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res 67: 7901-7906. (Pubitemid 47281386)
31. van Heusden GP, van der Zanden AL, Ferl RJ, Steensma HY (1996) Four Arabidopsis thaliana 14-3-3 protein isoforms can complement the lethal yeast bmh1 bmh2 double disruption. FEBS Lett 391: 252-256. (Pubitemid 26259767)
32. Ajjappala BS, Kim YS, Kim MS, Lee MY, Lee KY, et al. (2009) 14-3-3 gamma is stimulated by IL-3 and promotes cell proliferation. J Immunol 182: 1050-1060.
33. Li Z, Zhao J, Du Y, Park HR, Sun SY, et al. (2008) Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci U S A 105: 162-167.
34. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, et al. (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119: 1041-1054. (Pubitemid 40037616)
35. Jean D, Bar-Eli M (2001) Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: potential modality for cancer therapy. Crit Rev Immunol 21: 275-286. (Pubitemid 32959366)
36. Jean D, Bar-Eli M (2000) Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol Cell Biochem 212: 19-28.
37. Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M (1998) CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 273: 24884-24890. (Pubitemid 28454995)
38. Xie S, Price JE, Luca M, Jean D, Ronai Z, et al. (1997) Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene 15: 2069-2075. (Pubitemid 27489134)
39. Yang YM, Dolan LR, Ronai Z (1996) Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells. Oncogene 12: 2223-2233. (Pubitemid 26168431)
40. Leonard MO, Howell K, Madden SF, Costello CM, Higgins DG, et al. (2008) Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung. Am J Respir Crit Care Med 178: 977-983.
41. Shapiro DJ, Sharp PA, Wahli WW, Keller MJ (1988) A high-efficiency HeLa cell nuclear transcription extract. DNA 7: 47-55. (Pubitemid 18044633)
42. Beresford GW, Boss JM (2001) CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat Immunol 2: 652-657. (Pubitemid 32677634)
43. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921. (Pubitemid 32165345)
44. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, et al. (2003) The UCSC Genome Browser Database. Nucleic Acids Res 31: 51-54. (Pubitemid 36150331)